StockData
IRadimed Corp logo

IRadimed Corp (IRMD) stock

IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3054% above fair value
$83.45−1.39 (-1.64%)

Close on Nov 17, 2026Market cap $1.07BP/E 44.6Yield –

IRadimed operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

IRadimed's operating cash flow for the twelve months ending Sep 30, 2026 was $27.15M, up 8.5% year over year. For fiscal 2025 it was $24.95M, down 2.6% from the year before. Over ten years it grew 12.5% a year on average. The highest annual figure on record is $25.62M in fiscal 2024.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$24.95M-2.6%
FY2024Dec 31, 2024$25.62M+90.3%
FY2023Dec 31, 2023$13.47M+34.1%
FY2022Dec 31, 2022$10.04M-10.8%
FY2021Dec 31, 2021$11.26M+93.5%
FY2020Dec 31, 2020$5.82M-43.1%
FY2019Dec 31, 2019$10.23M+38.7%
FY2018Dec 31, 2018$7.38M+115.9%
FY2017Dec 31, 2017$3.42M-63.7%
FY2016Dec 31, 2016$9.41M+23.0%
FY2015Dec 31, 2015$7.65M+195.8%
FY2014Dec 31, 2014$2.59M+75.4%
FY2013Dec 31, 2013$1.47M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$7.00M+0.2%
Q2 FY2026Jun 30, 2026$5.94M-23.3%
Q1 FY2026Mar 31, 2026$8.29M+93.2%
Q4 FY2025Dec 31, 2025$5.92M-1.1%
Q3 FY2025Sep 30, 2025$6.99M-23.4%
Q2 FY2025Jun 30, 2025$7.75M+16.7%
Q1 FY2025Mar 31, 2025$4.29M+10.5%
Q4 FY2024Dec 31, 2024$5.99M+53.0%
Q3 FY2024Sep 30, 2024$9.12M+554.5%
Q2 FY2024Jun 30, 2024$6.64M+88.9%
Q1 FY2024Mar 31, 2024$3.88M-16.4%
Q4 FY2023Dec 31, 2023$3.91M+28.7%
Q3 FY2023Sep 30, 2023$1.39M-64.6%
Q2 FY2023Jun 30, 2023$3.51M+114.4%
Q1 FY2023Mar 31, 2023$4.65M+225.8%
Q4 FY2022Dec 31, 2022$3.04M-9.7%
Q3 FY2022Sep 30, 2022$3.94M+16.6%
Q2 FY2022Jun 30, 2022$1.64M-54.1%
Q1 FY2022Mar 31, 2022$1.43M+51.2%
Q4 FY2021Dec 31, 2021$3.37M+34.9%
Q3 FY2021Sep 30, 2021$3.38M+153.2%
Q2 FY2021Jun 30, 2021$3.57M+351.6%
Q1 FY2021Mar 31, 2021$943.08K-21.2%
Q4 FY2020Dec 31, 2020$2.50M-36.8%
Q3 FY2020Sep 30, 2020$1.33M-57.5%
Q2 FY2020Jun 30, 2020$790.60K-68.1%
Q1 FY2020Mar 31, 2020$1.20M+79.9%
Q4 FY2019Dec 31, 2019$3.95M+11.5%
Q3 FY2019Sep 30, 2019$3.14M+331.1%
Q2 FY2019Jun 30, 2019$2.48M+63.0%
Q1 FY2019Mar 31, 2019$665.20K-58.0%
Q4 FY2018Dec 31, 2018$3.54M+152.8%
Q3 FY2018Sep 30, 2018$727.93K-61.8%
Q2 FY2018Jun 30, 2018$1.52M+422.0%
Q1 FY2018Mar 31, 2018$1.58M–
Q4 FY2017Dec 31, 2017$1.40M-37.0%
Q3 FY2017Sep 30, 2017$1.91M–
Q2 FY2017Jun 30, 2017$291.53K–
Q1 FY2017Mar 31, 2017-$184.65K–
Q4 FY2016Dec 31, 2016$2.22M–

More IRadimed figures

See a number that looks wrong?